deucravacitinib
bms
['psoriasis', 'deucrava', 'deucra']
 news approves deucravacitinib for the treatment of adults with moderate-to-severe plaque #psoriasis who are candidates for systemic therapy or phototherapy, but is not recommended in combination with potent immunosuppressants.
#mednews 
The Psoriasis and Psoriatic Arthritis Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education.